25 XP   0   0   10

InspireMD Inc
Buy, Hold or Sell?

Let's analyse Inspiremd together

PenkeI guess you are interested in InspireMD Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of InspireMD Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about InspireMD Inc

I send you an email if I find something interesting about InspireMD Inc.

Quick analysis of Inspiremd (30 sec.)










What can you expect buying and holding a share of Inspiremd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.63
Expected worth in 1 year
$2.51
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$0.89
Return On Investment
47.9%

For what price can you sell your share?

Current Price per Share
$1.85
Expected price per share
$1.28 - $2.15
How sure are you?
50%

1. Valuation of Inspiremd (5 min.)




Live pricePrice per Share (EOD)

$1.85

Intrinsic Value Per Share

$-8.74 - $-4.81

Total Value Per Share

$-7.11 - $-3.18

2. Growth of Inspiremd (5 min.)




Is Inspiremd growing?

Current yearPrevious yearGrowGrow %
How rich?$39.5m$23.6m$12m33.8%

How much money is Inspiremd making?

Current yearPrevious yearGrowGrow %
Making money-$4.9m-$4.5m-$357.7k-7.2%
Net Profit Margin-320.3%-365.3%--

How much money comes from the company's main activities?

3. Financial Health of Inspiremd (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#179 / 334

Most Revenue
#250 / 334

Most Profit
#216 / 334

Most Efficient
#278 / 334

What can you expect buying and holding a share of Inspiremd? (5 min.)

Welcome investor! Inspiremd's management wants to use your money to grow the business. In return you get a share of Inspiremd.

What can you expect buying and holding a share of Inspiremd?

First you should know what it really means to hold a share of Inspiremd. And how you can make/lose money.

Speculation

The Price per Share of Inspiremd is $1.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inspiremd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inspiremd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.63. Based on the TTM, the Book Value Change Per Share is $0.22 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inspiremd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.22-12.0%-0.19-10.4%-0.20-10.7%-0.15-8.3%-0.15-8.2%
Usd Book Value Change Per Share0.3519.2%0.2212.0%-0.17-9.3%0.063.4%0.031.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.3519.2%0.2212.0%-0.17-9.3%0.063.4%0.031.7%
Usd Price Per Share2.81-2.43-1.89-1.89-1.00-
Price to Earnings Ratio-3.15--3.24--2.42--3.12--1.73-
Price-to-Total Gains Ratio7.92--0.38--11.23--67.04--33.94-
Price to Book Ratio1.73-1.88-1.77-2.62-1.95-
Price-to-Total Gains Ratio7.92--0.38--11.23--67.04--33.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.85
Number of shares540
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.220.06
Usd Total Gains Per Share0.220.06
Gains per Quarter (540 shares)119.6433.86
Gains per Year (540 shares)478.54135.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104794690135125
209579480271260
30143614270406395
40191419060542530
50239323850677665
60287128640813800
70335033430948935
8038283822010841070
9043074301012191205
10047854780013541340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.057.00.00.0%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%12.028.00.030.0%19.038.00.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.057.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%12.028.00.030.0%19.038.00.033.3%

Fundamentals of Inspiremd

About InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Fundamental data was last updated by Penke on 2024-04-11 16:10:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of InspireMD Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Inspiremd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inspiremd to the Medical Devices industry mean.
  • A Net Profit Margin of -306.9% means that $-3.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of InspireMD Inc:

  • The MRQ is -306.9%. The company is making a huge loss. -2
  • The TTM is -320.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-306.9%TTM-320.3%+13.3%
TTM-320.3%YOY-365.3%+45.1%
TTM-320.3%5Y-456.9%+136.7%
5Y-456.9%10Y-583.8%+126.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-306.9%-12.4%-294.5%
TTM-320.3%-20.4%-299.9%
YOY-365.3%-14.8%-350.5%
5Y-456.9%-21.3%-435.6%
10Y-583.8%-25.0%-558.8%
1.1.2. Return on Assets

Shows how efficient Inspiremd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inspiremd to the Medical Devices industry mean.
  • -11.3% Return on Assets means that Inspiremd generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of InspireMD Inc:

  • The MRQ is -11.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-13.0%+1.6%
TTM-13.0%YOY-15.6%+2.6%
TTM-13.0%5Y-16.2%+3.2%
5Y-16.2%10Y-25.2%+9.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.3%-4.1%-7.2%
TTM-13.0%-4.7%-8.3%
YOY-15.6%-4.8%-10.8%
5Y-16.2%-4.0%-12.2%
10Y-25.2%-5.2%-20.0%
1.1.3. Return on Equity

Shows how efficient Inspiremd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inspiremd to the Medical Devices industry mean.
  • -13.7% Return on Equity means Inspiremd generated $-0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of InspireMD Inc:

  • The MRQ is -13.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.7%TTM-16.8%+3.1%
TTM-16.8%YOY-20.3%+3.5%
TTM-16.8%5Y-24.2%+7.4%
5Y-24.2%10Y-36.7%+12.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.7%-4.2%-9.5%
TTM-16.8%-5.8%-11.0%
YOY-20.3%-5.7%-14.6%
5Y-24.2%-6.3%-17.9%
10Y-36.7%-7.1%-29.6%

1.2. Operating Efficiency of InspireMD Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Inspiremd is operating .

  • Measures how much profit Inspiremd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inspiremd to the Medical Devices industry mean.
  • An Operating Margin of -329.8% means the company generated $-3.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of InspireMD Inc:

  • The MRQ is -329.8%. The company is operating very inefficient. -2
  • The TTM is -343.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-329.8%TTM-343.0%+13.2%
TTM-343.0%YOY-374.1%+31.1%
TTM-343.0%5Y-457.7%+114.7%
5Y-457.7%10Y-563.0%+105.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-329.8%-24.3%-305.5%
TTM-343.0%-16.4%-326.6%
YOY-374.1%-13.7%-360.4%
5Y-457.7%-19.9%-437.8%
10Y-563.0%-24.5%-538.5%
1.2.2. Operating Ratio

Measures how efficient Inspiremd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 4.30 means that the operating costs are $4.30 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of InspireMD Inc:

  • The MRQ is 4.298. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.420. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.298TTM4.420-0.122
TTM4.420YOY4.720-0.300
TTM4.4205Y5.554-1.134
5Y5.55410Y6.606-1.052
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2981.442+2.856
TTM4.4201.439+2.981
YOY4.7201.431+3.289
5Y5.5541.436+4.118
10Y6.6061.374+5.232

1.3. Liquidity of InspireMD Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Inspiremd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.34 means the company has $7.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of InspireMD Inc:

  • The MRQ is 7.335. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.893. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.335TTM7.893-0.557
TTM7.893YOY6.385+1.507
TTM7.8935Y6.708+1.184
5Y6.70810Y4.408+2.300
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3352.726+4.609
TTM7.8932.732+5.161
YOY6.3853.510+2.875
5Y6.7083.617+3.091
10Y4.4083.499+0.909
1.3.2. Quick Ratio

Measures if Inspiremd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inspiremd to the Medical Devices industry mean.
  • A Quick Ratio of 11.66 means the company can pay off $11.66 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of InspireMD Inc:

  • The MRQ is 11.663. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.526. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.663TTM12.526-0.863
TTM12.526YOY10.222+2.304
TTM12.5265Y8.677+3.849
5Y8.67710Y5.292+3.384
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6631.491+10.172
TTM12.5261.633+10.893
YOY10.2222.113+8.109
5Y8.6772.295+6.382
10Y5.2922.255+3.037

1.4. Solvency of InspireMD Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Inspiremd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inspiremd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.17 means that Inspiremd assets are financed with 17.1% credit (debt) and the remaining percentage (100% - 17.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of InspireMD Inc:

  • The MRQ is 0.171. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.190. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.171TTM0.190-0.019
TTM0.190YOY0.221-0.031
TTM0.1905Y0.257-0.067
5Y0.25710Y0.581-0.325
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1710.389-0.218
TTM0.1900.386-0.196
YOY0.2210.335-0.114
5Y0.2570.442-0.185
10Y0.5810.461+0.120
1.4.2. Debt to Equity Ratio

Measures if Inspiremd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inspiremd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 20.6% means that company has $0.21 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of InspireMD Inc:

  • The MRQ is 0.206. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.248. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.206TTM0.248-0.042
TTM0.248YOY0.289-0.041
TTM0.2485Y0.390-0.142
5Y0.39010Y0.813-0.423
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2060.551-0.345
TTM0.2480.554-0.306
YOY0.2890.479-0.190
5Y0.3900.622-0.232
10Y0.8130.674+0.139

2. Market Valuation of InspireMD Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inspiremd generates.

  • Above 15 is considered overpriced but always compare Inspiremd to the Medical Devices industry mean.
  • A PE ratio of -3.15 means the investor is paying $-3.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of InspireMD Inc:

  • The EOD is -2.077. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.154. Based on the earnings, the company is expensive. -2
  • The TTM is -3.244. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.077MRQ-3.154+1.078
MRQ-3.154TTM-3.244+0.090
TTM-3.244YOY-2.419-0.825
TTM-3.2445Y-3.116-0.128
5Y-3.11610Y-1.726-1.391
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.077-1.077-1.000
MRQ-3.154-1.704-1.450
TTM-3.244-2.081-1.163
YOY-2.419-2.978+0.559
5Y-3.116-2.379-0.737
10Y-1.726-1.726+0.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of InspireMD Inc:

  • The EOD is -2.556. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.882. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.082. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.556MRQ-3.882+1.326
MRQ-3.882TTM-4.082+0.200
TTM-4.082YOY-2.825-1.257
TTM-4.0825Y-3.566-0.516
5Y-3.56610Y-1.939-1.627
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.556-0.932-1.624
MRQ-3.882-1.578-2.304
TTM-4.082-2.973-1.109
YOY-2.825-6.318+3.493
5Y-3.566-5.307+1.741
10Y-1.939-5.171+3.232
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Inspiremd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.73 means the investor is paying $1.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of InspireMD Inc:

  • The EOD is 1.137. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.726. Based on the equity, the company is underpriced. +1
  • The TTM is 1.882. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.137MRQ1.726-0.590
MRQ1.726TTM1.882-0.155
TTM1.882YOY1.774+0.108
TTM1.8825Y2.621-0.740
5Y2.62110Y1.946+0.676
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.1371.876-0.739
MRQ1.7262.372-0.646
TTM1.8822.434-0.552
YOY1.7743.217-1.443
5Y2.6213.893-1.272
10Y1.9464.245-2.299
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of InspireMD Inc.

3.1. Institutions holding InspireMD Inc

Institutions are holding 44.079% of the shares of InspireMD Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC17.61940.347441329122364862133.7554
2023-12-31Orbimed Advisors, LLC9.09510.1197213340527300014.6742
2023-12-31Marshall Wace Asset Management Ltd7.93130.0089186040500
2023-12-31Soleus Capital Management, L.P.5.87520.4297137812800
2023-12-31Rosalind Advisors, Inc.3.94432.14129251949251940
2023-12-31Velan Capital Investment Management LP3.85411.482790402900
2023-12-31PURA VIDA INVESTMENTS, LLC1.92060.19314505179432626.4819
2023-12-31Millennium Management LLC1.48480.000434827414244869.208
2023-09-30Point72 Asset Management, L.P.0.9340.00212190932190930
2023-12-31Morgan Stanley - Brokerage Accounts0.27080635301803039.6264
2023-12-31Mesirow Fin Investmt Mgmt Intl Equity0.12790.003130000300000
2023-12-31Northern Trust Corp0.1212028438284380
2023-12-31HighTower Advisors, LLC0.11620.0001272625001.8683
2023-12-31Elias Asset Management Inc0.10660.00982500000
2023-12-31Hollencrest Securities, LLC0.08530.00532000000
2023-12-31Avestar Capital, LLC0.08530.00642000000
2023-12-31Geode Capital Management, LLC0.077801824400
2023-12-31Renaissance Technologies Corp0.06390.000115000-1700-10.1796
2023-12-31Mckinley Carter Wealth Services Inc0.04260.002110000100000
2023-12-31AdvisorNet Financial, Inc0.03740.0023878300
Total 53.79384.754412618214+4104191+32.5%

3.2. Funds holding InspireMD Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.07780.00031824400
Total 0.07780.00031824400.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of InspireMD Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3550.222+60%-0.172+148%0.063+466%0.031+1027%
Book Value Per Share--1.6281.367+19%1.009+61%0.944+72%0.517+215%
Current Ratio--7.3357.893-7%6.385+15%6.708+9%4.408+66%
Debt To Asset Ratio--0.1710.190-10%0.221-23%0.257-33%0.581-71%
Debt To Equity Ratio--0.2060.248-17%0.289-29%0.390-47%0.813-75%
Dividend Per Share----0%-0%-0%-0%
Eps---0.223-0.193-13%-0.197-12%-0.154-31%-0.151-32%
Free Cash Flow Per Share---0.181-0.163-10%-0.171-6%-0.137-24%-0.127-30%
Free Cash Flow To Equity Per Share---0.1810.637-128%0.227-180%0.226-180%0.104-273%
Gross Profit Margin--1.2421.194+4%1.199+4%1.209+3%1.240+0%
Intrinsic Value_10Y_max---4.812--------
Intrinsic Value_10Y_min---8.738--------
Intrinsic Value_1Y_max---0.504--------
Intrinsic Value_1Y_min---0.683--------
Intrinsic Value_3Y_max---1.497--------
Intrinsic Value_3Y_min---2.230--------
Intrinsic Value_5Y_max---2.471--------
Intrinsic Value_5Y_min---3.963--------
Market Cap43394710.000-57%68193588.61066176602.230+3%44215691.000+54%46144930.246+48%24323640.167+180%
Net Profit Margin---3.069-3.203+4%-3.653+19%-4.569+49%-5.838+90%
Operating Margin---3.298-3.430+4%-3.741+13%-4.577+39%-5.630+71%
Operating Ratio--4.2984.420-3%4.720-9%5.554-23%6.606-35%
Pb Ratio1.137-52%1.7261.882-8%1.774-3%2.621-34%1.946-11%
Pe Ratio-2.077+34%-3.154-3.244+3%-2.419-23%-3.116-1%-1.726-45%
Price Per Share1.850-52%2.8102.430+16%1.885+49%1.889+49%0.998+182%
Price To Free Cash Flow Ratio-2.556+34%-3.882-4.082+5%-2.825-27%-3.566-8%-1.939-50%
Price To Total Gains Ratio5.213-52%7.919-0.381+105%-11.230+242%-67.037+947%-33.937+529%
Quick Ratio--11.66312.526-7%10.222+14%8.677+34%5.292+120%
Return On Assets---0.113-0.130+14%-0.156+37%-0.162+43%-0.252+122%
Return On Equity---0.137-0.168+23%-0.203+48%-0.242+77%-0.367+168%
Total Gains Per Share--0.3550.222+60%-0.172+148%0.063+466%0.031+1027%
Usd Book Value--39501000.00035749250.000+10%23677250.000+67%22885600.000+73%12505150.000+216%
Usd Book Value Change Per Share--0.3550.222+60%-0.172+148%0.063+466%0.031+1027%
Usd Book Value Per Share--1.6281.367+19%1.009+61%0.944+72%0.517+215%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.223-0.193-13%-0.197-12%-0.154-31%-0.151-32%
Usd Free Cash Flow---4391999.000-4189249.750-5%-4003750.000-9%-3279449.950-25%-3007274.975-32%
Usd Free Cash Flow Per Share---0.181-0.163-10%-0.171-6%-0.137-24%-0.127-30%
Usd Free Cash Flow To Equity Per Share---0.1810.637-128%0.227-180%0.226-180%0.104-273%
Usd Market Cap43394710.000-57%68193588.61066176602.230+3%44215691.000+54%46144930.246+48%24323640.167+180%
Usd Price Per Share1.850-52%2.8102.430+16%1.885+49%1.889+49%0.998+182%
Usd Profit---5405000.000-4947750.000-8%-4590000.000-15%-3682650.000-32%-3471900.000-36%
Usd Revenue--1761000.0001551250.000+14%1292750.000+36%1103850.000+60%886500.000+99%
Usd Total Gains Per Share--0.3550.222+60%-0.172+148%0.063+466%0.031+1027%
 EOD+2 -6MRQTTM+21 -13YOY+25 -95Y+25 -910Y+25 -9

4.2. Fundamental Score

Let's check the fundamental score of InspireMD Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.077
Price to Book Ratio (EOD)Between0-11.137
Net Profit Margin (MRQ)Greater than0-3.069
Operating Margin (MRQ)Greater than0-3.298
Quick Ratio (MRQ)Greater than111.663
Current Ratio (MRQ)Greater than17.335
Debt to Asset Ratio (MRQ)Less than10.171
Debt to Equity Ratio (MRQ)Less than10.206
Return on Equity (MRQ)Greater than0.15-0.137
Return on Assets (MRQ)Greater than0.05-0.113
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of InspireMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.036
Ma 20Greater thanMa 502.207
Ma 50Greater thanMa 1002.405
Ma 100Greater thanMa 2002.541
OpenGreater thanClose1.905
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets47,643
Total Liabilities8,142
Total Stockholder Equity39,501
 As reported
Total Liabilities 8,142
Total Stockholder Equity+ 39,501
Total Assets = 47,643

Assets

Total Assets47,643
Total Current Assets44,159
Long-term Assets3,484
Total Current Assets
Cash And Cash Equivalents 9,640
Short-term Investments 29,383
Net Receivables 1,804
Other Current Assets 3,030
Total Current Assets  (as reported)44,159
Total Current Assets  (calculated)43,857
+/- 302
Long-term Assets
Property Plant Equipment 2,533
Long-term Assets Other 951
Long-term Assets  (as reported)3,484
Long-term Assets  (calculated)3,484
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,020
Long-term Liabilities2,122
Total Stockholder Equity39,501
Total Current Liabilities
Short-term Debt 557
Accounts payable 939
Other Current Liabilities 4,524
Total Current Liabilities  (as reported)6,020
Total Current Liabilities  (calculated)6,020
+/-0
Long-term Liabilities
Capital Lease Obligations 1,595
Long-term Liabilities  (as reported)2,122
Long-term Liabilities  (calculated)1,595
+/- 527
Total Stockholder Equity
Common Stock2
Retained Earnings -221,501
Other Stockholders Equity 261,000
Total Stockholder Equity (as reported)39,501
Total Stockholder Equity (calculated)39,501
+/-0
Other
Capital Stock2
Cash and Short Term Investments 39,023
Common Stock Shares Outstanding 24,268
Liabilities and Stockholders Equity 47,643
Net Debt -9,640
Net Invested Capital 39,501
Net Working Capital 38,139
Property Plant and Equipment Gross 4,573
Short Long Term Debt Total 1,595



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
5
0
0
17
6
1
0
12,720
11,343
12,070
10,465
8,527
16,010
13,615
11,597
9,797
20,745
17,687
23,970
19,505
13,958
9,891
11,459
17,724
13,562
9,761
5,778
4,244
3,020
12,457
9,410
10,512
8,907
7,113
6,107
7,285
9,471
13,933
12,288
10,057
9,284
11,622
9,880
7,385
17,740
15,609
17,777
48,635
46,375
42,606
39,712
35,171
32,766
28,061
24,653
19,921
53,638
50,020
47,643
47,64350,02053,63819,92124,65328,06132,76635,17139,71242,60646,37548,63517,77715,60917,7407,3859,88011,6229,28410,05712,28813,9339,4717,2856,1077,1138,90710,5129,41012,4573,0204,2445,7789,76113,56217,72411,4599,89113,95819,50523,97017,68720,7459,79711,59713,61516,0108,52710,46512,07011,34312,720016170050
   > Total Current Assets 
0
5
0
0
17
6
1
0
12,216
10,836
11,530
9,830
7,801
14,310
11,974
9,102
7,102
18,905
15,644
21,600
17,211
11,630
7,739
9,368
16,042
11,994
8,561
4,632
3,322
1,875
11,621
8,594
9,582
7,993
6,155
5,155
6,199
8,241
13,087
11,419
7,970
7,222
9,574
7,810
5,436
15,871
13,336
15,339
46,250
43,922
40,091
37,094
32,632
29,500
24,692
21,326
16,703
50,520
46,728
44,159
44,15946,72850,52016,70321,32624,69229,50032,63237,09440,09143,92246,25015,33913,33615,8715,4367,8109,5747,2227,97011,41913,0878,2416,1995,1556,1557,9939,5828,59411,6211,8753,3224,6328,56111,99416,0429,3687,73911,63017,21121,60015,64418,9057,1029,10211,97414,3107,8019,83011,53010,83612,216016170050
       Cash And Cash Equivalents 
0
5
0
0
17
6
1
0
9,615
8,070
7,485
5,094
3,351
10,280
8,297
5,433
2,514
14,820
11,440
17,540
13,706
8,988
4,978
6,300
13,186
9,768
6,509
3,257
1,999
885
10,468
7,516
8,572
6,879
4,765
3,710
4,637
6,442
11,247
9,384
5,807
4,823
7,154
5,514
3,141
13,861
10,882
12,645
44,034
41,419
13,059
12,004
7,798
6,393
3,934
4,632
4,228
11,545
13,869
9,640
9,64013,86911,5454,2284,6323,9346,3937,79812,00413,05941,41944,03412,64510,88213,8613,1415,5147,1544,8235,8079,38411,2476,4424,6373,7104,7656,8798,5727,51610,4688851,9993,2576,5099,76813,1866,3004,9788,98813,70617,54011,44014,8202,5145,4338,29710,2803,3515,0947,4858,0709,615016170050
       Short-term Investments 
0
0
0
0
0
0
0
0
342
343
40
91
39
37
37
93
91
93
93
93
93
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,012
22,036
22,053
20,078
17,111
13,171
8,657
35,448
29,159
29,383
29,38329,15935,4488,65713,17117,11120,07822,05322,03624,01200000000000000000000000000000939393939193373739914034334200000000
       Net Receivables 
0
0
0
0
0
0
0
0
567
799
1,895
2,402
2,246
2,090
1,486
1,485
2,424
1,925
2,575
2,240
1,959
913
941
994
997
921
863
547
750
562
681
513
660
612
705
850
992
1,091
879
820
650
1,137
982
973
1,030
568
897
945
825
1,098
1,112
1,389
1,204
1,354
1,373
1,247
1,727
1,782
1,408
1,804
1,8041,4081,7821,7271,2471,3731,3541,2041,3891,1121,0988259458975681,0309739821,1376508208791,0919928507056126605136815627505478639219979949419131,9592,2402,5751,9252,4241,4851,4862,0902,2462,4021,89579956700000000
       Other Current Assets 
0
0
0
0
0
0
0
0
371
414
143
163
128
200
93
187
182
567
237
141
203
215
138
330
109
76
108
75
62
41
107
65
21
73
109
62
53
71
145
81
66
44
155
87
63
40
169
334
207
63
773
522
291
221
860
15,073
10,778
8,469
-30
3,030
3,030-308,46910,77815,07386022129152277363207334169406387155446681145715362109732165107416275108761093301382152031412375671821879320012816314341437100000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
504
507
540
635
726
1,700
1,641
2,495
2,695
1,840
2,043
0
2,294
2,328
2,152
2,091
1,682
1,568
1,200
1,146
922
1,145
836
816
930
914
958
952
1,086
1,230
846
869
2,087
2,062
2,048
2,070
1,949
1,869
2,273
2,438
2,385
2,453
2,515
2,618
2,539
3,266
3,369
3,327
3,218
3,118
3,292
3,484
3,4843,2923,1183,2183,3273,3693,2662,5392,6182,5152,4532,3852,4382,2731,8691,9492,0702,0482,0622,0878698461,2301,0869529589149308168361,1459221,1461,2001,5681,6822,0912,1522,3282,29402,0431,8402,6952,4951,6411,70072663554050750400000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
303
304
346
420
465
460
463
479
467
550
591
652
624
663
636
622
584
546
516
472
436
412
379
379
496
459
495
476
444
431
400
421
1,556
1,555
1,513
1,484
1,360
1,249
1,630
1,713
1,662
1,694
1,729
1,713
1,624
2,417
2,511
2,471
2,359
2,261
2,445
2,533
2,5332,4452,2612,3592,4712,5112,4171,6241,7131,7291,6941,6621,7131,6301,2491,3601,4841,5131,5551,55642140043144447649545949637937941243647251654658462263666362465259155046747946346046542034630430300000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000400000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
201
203
194
215
261
1,243
1,178
2,016
2,228
1,290
1,452
1,710
1,670
1,665
1,516
1,469
1,098
1,022
684
674
486
733
457
437
434
455
463
476
642
799
446
448
531
507
535
586
589
620
643
725
723
759
786
42,330
915
849
858
856
859
857
0
0
0085785985685884991542,3307867597237256436205895865355075314484467996424764634554344374577334866746841,0221,0981,4691,5161,6651,6701,7101,4521,2902,2282,0161,1781,24326121519420320100000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119
0
85
0
290
0
0
0
0
0
0
155
310
0
0
49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000490031015500000029008501190000000000000000000000000
> Total Liabilities 
0
3
0
0
8
8
8
10
4,996
4,183
3,855
3,711
3,725
10,630
14,371
11,393
13,200
4,643
4,679
15,330
15,892
16,755
16,272
14,246
12,339
11,186
10,335
8,724
7,639
8,113
6,229
5,365
2,798
3,165
3,333
3,380
6,241
5,373
2,981
3,525
4,417
3,710
3,726
4,497
3,908
4,526
4,329
5,614
4,681
5,545
5,543
6,180
5,467
7,024
6,191
7,260
6,495
6,825
6,763
8,142
8,1426,7636,8256,4957,2606,1917,0245,4676,1805,5435,5454,6815,6144,3294,5263,9084,4973,7263,7104,4173,5252,9815,3736,2413,3803,3333,1652,7985,3656,2298,1137,6398,72410,33511,18612,33914,24616,27216,75515,89215,3304,6794,64313,20011,39314,37110,6303,7253,7113,8554,1834,996108880030
   > Total Current Liabilities 
0
3
0
0
8
8
8
10
4,759
3,919
3,598
3,441
3,408
3,550
3,363
9,532
10,873
4,043
4,042
6,120
7,508
9,124
9,551
8,473
7,502
7,329
7,530
6,919
7,055
7,451
5,625
4,778
2,258
2,593
2,723
2,482
2,955
2,480
2,373
2,920
2,637
1,945
2,323
3,115
2,603
3,249
2,569
3,705
2,866
3,679
3,720
4,347
3,691
4,712
3,961
5,070
4,383
4,829
4,690
6,020
6,0204,6904,8294,3835,0703,9614,7123,6914,3473,7203,6792,8663,7052,5693,2492,6033,1152,3231,9452,6372,9202,3732,4802,9552,4822,7232,5932,2584,7785,6257,4517,0556,9197,5307,3297,5028,4739,5519,1247,5086,1204,0424,04310,8739,5323,3633,5503,4083,4413,5983,9194,759108880030
       Short-term Debt 
0
0
0
0
0
0
0
0
1,451
268
183
94
-3,216
0
0
6,461
7,385
0
0
9,774
2,099
3,037
3,710
3,809
3,909
4,015
4,123
4,234
4,294
3,919
3,655
2,680
0
0
0
0
2,391
1,952
0
0
0
0
352
362
367
374
357
400
381
412
411
420
413
424
416
419
417
418
497
557
55749741841741941642441342041141238140035737436736235200001,9522,39100002,6803,6553,9194,2944,2344,1234,0153,9093,8093,7103,0372,0999,774007,3856,46100-3,216941832681,45100000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,774
0
0
0
3,809
0
0
0
4,149
0
0
0
2,680
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000002,6800004,1490003,8090009,7740000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
470
3,107
562
814
3,191
440
556
501
416
831
850
1,623
1,405
1,529
1,548
909
665
491
834
512
453
1,198
409
618
351
473
402
328
512
476
456
929
872
618
687
646
562
458
427
236
401
739
556
893
900
1,127
404
659
607
768
600
939
9396007686076594041,1279008935567394012364274585626466876188729294564765123284024733516184091,1984535128344916659091,5481,5291,4051,6238508314165015564403,1918145623,10747000000000
       Other Current Liabilities 
0
3
0
0
8
8
8
10
1,958
2,888
2,337
2,217
3,216
3,100
2,628
2,376
2,885
3,028
3,016
3,291
3,814
4,344
4,113
3,576
2,766
2,654
2,403
2,006
2,139
2,223
1,526
1,447
1,884
2,066
2,293
2,134
26
26
1,891
1,966
1,740
1,307
1,265
2,087
1,657
2,400
1,766
3,069
2,084
2,528
2,753
3,034
2,378
3,161
3,141
3,992
3,359
3,643
3,593
4,524
4,5243,5933,6433,3593,9923,1413,1612,3783,0342,7532,5282,0843,0691,7662,4001,6572,0871,2651,3071,7401,9661,89126262,1342,2932,0661,8841,4471,5262,2232,1392,0062,4032,6542,7663,5764,1134,3443,8143,2913,0163,0282,8852,3762,6283,1003,2162,2172,3372,8881,958108880030
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
237
264
257
270
317
7,080
11,008
1,861
2,327
600
637
0
8,384
7,631
6,721
5,773
4,837
3,857
2,805
1,805
584
662
604
587
540
572
610
898
3,286
2,893
608
605
1,780
1,765
1,403
1,382
1,305
1,277
1,760
1,909
1,815
1,866
1,823
1,833
1,776
2,312
2,230
2,190
2,112
1,996
2,073
2,122
2,1222,0731,9962,1122,1902,2302,3121,7761,8331,8231,8661,8151,9091,7601,2771,3051,3821,4031,7651,7806056082,8933,2868986105725405876046625841,8052,8053,8574,8375,7736,7217,6318,38406376002,3271,86111,0087,08031727025726423700000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,748
6,886
6,002
5,086
4,138
3,159
0
1,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000001,09903,1594,1385,0866,0026,8867,74800000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119
0
85
0
290
0
0
0
0
0
0
155
310
0
0
49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000490031015500000029008501190000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
274
1,779
2,264
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000002,2641,77927400000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
237
264
257
270
317
354
394
451
495
600
637
610
636
745
719
687
699
698
658
706
584
662
604
587
540
572
610
624
1,507
629
608
605
642
670
704
729
761
801
843
910
921
962
992
1,052
1,098
962
969
995
1,031
1,026
0
0
001,0261,0319959699621,0981,0529929629219108438017617297046706426056086291,50762461057254058760466258470665869869968771974563661063760049545139435431727025726423700000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
310
0
0
0
153
0
0
0
0
0
123
0
0
0
0
0
0
872
310
0
0
49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000004900310872000000123000001530003100000000000000000000
> Total Stockholder Equity
0
2
0
0
9
-2
-7
-10
7,724
7,160
8,215
6,754
4,802
5,390
-756
204
-3,403
16,102
13,008
8,639
3,613
-2,797
-6,381
-2,787
5,385
2,376
-574
-2,946
-3,395
-5,093
6,228
4,045
7,714
5,742
3,780
2,727
1,044
4,098
10,952
8,763
5,640
5,574
7,896
5,383
3,477
13,214
11,280
12,163
43,954
40,830
37,063
33,532
29,704
25,742
21,870
17,393
13,426
46,813
43,257
39,501
39,50143,25746,81313,42617,39321,87025,74229,70433,53237,06340,83043,95412,16311,28013,2143,4775,3837,8965,5745,6408,76310,9524,0981,0442,7273,7805,7427,7144,0456,228-5,093-3,395-2,946-5742,3765,385-2,787-6,381-2,7973,6138,63913,00816,102-3,403204-7565,3904,8026,7548,2157,1607,724-10-7-290020
   Common Stock
0
0
0
0
0
0
0
0
6
6
6
7
7
10
7
2
2
3
3
3
3
3
4
4
7
7
7
1
1
1
3
0
1
1
1
5
0
0
4
4
0
0
0
0
0
3
3
5
1
1
1
1
1
1
1
1
1
2
2
2
2221111111115330000044005111031117774433333227107766600000000
   Retained Earnings Total Equity00-210,9180000000-174,926-171,419-168,176-164,323-162,090-159,610-157,632-155,075-153,005-150,799-147,592-145,379-143,368-142,741-140,352-138,853-136,767-134,473-131,914-129,593-127,585-125,605-122,9960-116,501-112,623-107,411-102,621-95,846-88,284000000000-28,408-26,125000000000
   Accumulated Other Comprehensive Income 00000000000-1,574-1,574000-1,455000-1,299000-1,165000-1,099000-957000-875-710-7100-7100-63400000-40300000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
33,279
36,617
0
0
0
0
0
0
0
0
0
91,894
93,046
96,236
104,620
118,001
118,870
0
120,049
122,209
122,491
135,821
135,959
142,186
142,508
142,632
143,079
143,785
147,466
156,327
156,351
156,439
158,579
162,971
163,015
163,087
175,301
175,600
180,334
215,372
215,755
0
0
0
0
0
0
0
257,729
0
0
00257,7290000000215,755215,372180,334175,600175,301163,087163,015162,971158,579156,439156,351156,327147,466143,785143,079142,632142,508142,186135,959135,821122,491122,209120,0490118,870118,001104,62096,23693,04691,89400000000036,61733,279000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
12
0
0
32
32
32
32
31,589
33,279
36,617
43,388
44,576
49,100
50,464
53,349
54,628
89,079
89,930
0
91,894
93,046
96,236
104,620
118,001
118,870
119,561
120,049
122,209
122,491
135,821
135,959
142,186
142,508
142,632
143,079
143,785
147,466
156,327
156,351
156,439
158,579
162,971
163,015
163,087
175,301
175,600
180,334
215,372
215,755
216,059
216,625
217,278
217,952
218,609
218,977
219,266
257,729
259,351
261,000
261,000259,351257,729219,266218,977218,609217,952217,278216,625216,059215,755215,372180,334175,600175,301163,087163,015162,971158,579156,439156,351156,327147,466143,785143,079142,632142,508142,186135,959135,821122,491122,209120,049119,561118,870118,001104,62096,23693,04691,894089,93089,07954,62853,34950,46449,10044,57643,38836,61733,27931,5893232323200120



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,205
Cost of Revenue-4,398
Gross Profit1,8071,807
 
Operating Income (+$)
Gross Profit1,807
Operating Expense-22,694
Operating Income-20,887-20,887
 
Operating Expense (+$)
Research Development7,981
Selling General Administrative11,104
Selling And Marketing Expenses3,865
Operating Expense22,69422,950
 
Net Interest Income (+$)
Interest Income1,292
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,292
 
Pretax Income (+$)
Operating Income-20,887
Net Interest Income1,292
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,851-21,923
EBIT - interestExpense = -20,887
-19,851
-19,916
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-20,887-19,851
Earnings Before Interest and Taxes (EBITDA)-20,655
 
After tax Income (+$)
Income Before Tax-19,851
Tax Provision-65
Net Income From Continuing Ops-19,916-19,916
Net Income-19,916
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses27,092
Total Other Income/Expenses Net1,036-1,292
 

Technical Analysis of Inspiremd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inspiremd. The general trend of Inspiremd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inspiremd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of InspireMD Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.89 < 2.15 < 2.15.

The bearish price targets are: 1.58 > 1.3 > 1.28.

Tweet this
InspireMD Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of InspireMD Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

InspireMD Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of InspireMD Inc. The current macd is -0.12223878.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inspiremd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Inspiremd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Inspiremd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
InspireMD Inc Daily Moving Average Convergence/Divergence (MACD) ChartInspireMD Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of InspireMD Inc. The current adx is 18.05.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Inspiremd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
InspireMD Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of InspireMD Inc. The current sar is 2.33447234.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
InspireMD Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of InspireMD Inc. The current rsi is 29.04. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
InspireMD Inc Daily Relative Strength Index (RSI) ChartInspireMD Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of InspireMD Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inspiremd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
InspireMD Inc Daily Stochastic Oscillator ChartInspireMD Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of InspireMD Inc. The current cci is -209.59790495.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
InspireMD Inc Daily Commodity Channel Index (CCI) ChartInspireMD Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of InspireMD Inc. The current cmo is -50.75057913.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
InspireMD Inc Daily Chande Momentum Oscillator (CMO) ChartInspireMD Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of InspireMD Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
InspireMD Inc Daily Williams %R ChartInspireMD Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of InspireMD Inc.

InspireMD Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of InspireMD Inc. The current atr is 0.14376391.

InspireMD Inc Daily Average True Range (ATR) ChartInspireMD Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of InspireMD Inc. The current obv is 4,401,294.

InspireMD Inc Daily On-Balance Volume (OBV) ChartInspireMD Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of InspireMD Inc. The current mfi is 33.74.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
InspireMD Inc Daily Money Flow Index (MFI) ChartInspireMD Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for InspireMD Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

InspireMD Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of InspireMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.036
Ma 20Greater thanMa 502.207
Ma 50Greater thanMa 1002.405
Ma 100Greater thanMa 2002.541
OpenGreater thanClose1.905
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Inspiremd with someone you think should read this too:
  • Are you bullish or bearish on Inspiremd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inspiremd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about InspireMD Inc

I send you an email if I find something interesting about InspireMD Inc.


Comments

How you think about this?

Leave a comment

Stay informed about InspireMD Inc.

Receive notifications about InspireMD Inc in your mailbox!